Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
NG Industries Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹115.00 |
|---|---|
| Day's Range | ₹115.00 - ₹115.00 |
| Open | ₹115.00 |
| 52 Week Range | ₹111.00 - ₹162.00 |
| Volume | 20 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 0.02 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 3.04 |
| Price/Earning (TTM) | 22.25 |
| TTM EPS (₹) | 5.17 |
| P/E Ratio | 7.06 |
| Book Value(₹) | 1.15 |
| PAT Margin (%) | 46.77 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 23.83 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 165.47 | 44.68 |
| Expenses | N/A | N/A |
| PBT | 91.42 | -28.21 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 77.4 | -24.34 |
About NG Industries Ltd.
| Founded | 1994 |
|---|
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,70,269.65 | 1,960.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,22,223.75 | 8,371.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,91,325.03 | 5,030.00 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,28,277.48 | 8,921.50 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,17,138.71 | 1,450.00 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,11,570.80 | 1,118.50 | 835.50 - 835.50 |
| Lupin Ltd. | 1,08,639.01 | 2,376.00 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,04,042.93 | 1,069.00 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,01,638.31 | 2,461.00 | 1,909.70 - 1,909.70 |
| Laurus Labs Ltd. | 99,174.31 | 1,835.50 | 810.05 - 810.05 |
No Records Found
Latest News
Aug
5
2026
Posted on Aug 5th 2026
Morepen Laboratories - Quaterly Results
The sales surged to Rs. 5410.41 millions, up 38.27% for the June 2026 quarter as against Rs. 3912.84 millions during the corresponding quarter previous year.Net Profit witnessed a 569.88% growth almost the double from Rs. 80.61 millions to Rs. 539.99 millions of same quarter last year.OP of the company witnessed a marginal growth to 849.09 millions from 230.44 millions in the same quarter last year.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 5410.41 | 3912.84 | 38.27 | 5410.41 | 3912.84 | 38.27 | 16811.95 | 15545.35 | 8.15 |
| Other Income | 53.11 | 40.92 | 29.79 | 53.11 | 40.92 | 29.79 | 214.95 | 157.20 | 36.74 |
| PBIDT | 849.09 | 230.44 | 268.46 | 849.09 | 230.44 | 268.46 | 1335.74 | 1691.31 | -21.02 |
| Interest | 47.78 | 38.12 | 25.34 | 47.78 | 38.12 | 25.34 | 160.97 | 71.03 | 126.62 |
| PBDT | 801.31 | 192.32 | 316.65 | 801.31 | 192.32 | 316.65 | 1185.73 | 1620.28 | -26.82 |
| Depreciation | 79.79 | 78.79 | 1.27 | 79.79 | 78.79 | 1.27 | 293.08 | 244.42 | 19.91 |
| PBT | 721.52 | 113.53 | 535.53 | 721.52 | 113.53 | 535.53 | 892.65 | 1375.86 | -35.12 |
| TAX | 181.53 | 32.92 | 451.43 | 181.53 | 32.92 | 451.43 | 232.07 | 360.10 | -35.55 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 84.92 | 47.27 | 79.65 |
| PAT | 539.99 | 80.61 | 569.88 | 539.99 | 80.61 | 569.88 | 660.58 | 1015.76 | -34.97 |
| Equity | 1095.84 | 1095.84 | 0.00 | 1095.84 | 1095.84 | 0.00 | 1095.84 | 1095.84 | 0.00 |
| PBIDTM(%) | 15.69 | 5.89 | 166.48 | 15.69 | 5.89 | 166.48 | 7.95 | 10.88 | -26.97 |
Read More
Aug
5
2026
Posted on Aug 5th 2026
Syschem (India) - Quaterly Results
A slight decline in the revenue of Rs. 1259.48 millions was seen for the June 2026 quarter as against Rs. 1267.58 millions during year-ago period.The Net Loss for the quarter ended June 2026 is Rs. -16.68 millions as compared to Net Profit of Rs. 16.74 millions of corresponding quarter ended June 2025Operating profit for the quarter ended June 2026 decreased to 5.93 millions as compared to 24.70 millions of corresponding quarter ended June 2025.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 1259.48 | 1267.58 | -0.64 | 1259.48 | 1267.58 | -0.64 | 6546.26 | 3862.31 | 69.49 |
| Other Income | 0.47 | 0.05 | 840.00 | 0.47 | 0.05 | 840.00 | 0.21 | 0.42 | -50.00 |
| PBIDT | 5.93 | 24.70 | -75.99 | 5.93 | 24.70 | -75.99 | 211.13 | 40.24 | 424.68 |
| Interest | 4.90 | 0.39 | 1156.41 | 4.90 | 0.39 | 1156.41 | 22.64 | 0.66 | 3330.30 |
| PBDT | 1.03 | 24.31 | -95.76 | 1.03 | 24.31 | -95.76 | 188.49 | 39.58 | 376.23 |
| Depreciation | 15.55 | 7.57 | 105.42 | 15.55 | 7.57 | 105.42 | 40.63 | 29.47 | 37.87 |
| PBT | -14.52 | 16.74 | -186.74 | -14.52 | 16.74 | -186.74 | 147.86 | 10.11 | 1362.51 |
| TAX | 2.16 | 0.00 | 0.00 | 2.16 | 0.00 | 0.00 | 38.58 | 5.52 | 598.91 |
| Deferred Tax | 2.16 | 0.00 | 0.00 | 2.16 | 0.00 | 0.00 | 38.58 | 5.52 | 598.91 |
| PAT | -16.68 | 16.74 | -199.64 | -16.68 | 16.74 | -199.64 | 109.28 | 4.59 | 2280.83 |
| Equity | 536.16 | 435.13 | 23.22 | 536.16 | 435.13 | 23.22 | 490.13 | 435.13 | 12.64 |
| PBIDTM(%) | 0.47 | 1.95 | -75.84 | 0.47 | 1.95 | -75.84 | 3.23 | 1.04 | 209.55 |
Read More
Aug
5
2026
Posted on Aug 5th 2026
Dr. Agarwal's Health - Quaterly Results
A decent increase of about 26.81% in the sales to Rs. 3826.20 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 3017.20 millions during the year-ago period.Handsome Net Profit growth of 64.89% reported above the corresponding previous quarter figure of Rs. 166.70 millions to Rs. 101.10 millions.Operating Profit saw a handsome growth to 989.90 millions from 798.30 millions in the quarter ended June 2026.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 3826.20 | 3017.20 | 26.81 | 3826.20 | 3017.20 | 26.81 | 12933.90 | 10438.90 | 23.90 |
| Other Income | 34.20 | 130.30 | -73.75 | 34.20 | 130.30 | -73.75 | 331.60 | 538.10 | -38.38 |
| PBIDT | 989.90 | 798.30 | 24.00 | 989.90 | 798.30 | 24.00 | 3407.30 | 2989.10 | 13.99 |
| Interest | 189.60 | 193.20 | -1.86 | 189.60 | 193.20 | -1.86 | 730.40 | 903.00 | -19.11 |
| PBDT | 800.30 | 598.00 | 33.83 | 800.30 | 598.00 | 33.83 | 2606.40 | 1946.10 | 33.93 |
| Depreciation | 575.30 | 442.10 | 30.13 | 575.30 | 442.10 | 30.13 | 1966.80 | 1560.10 | 26.07 |
| PBT | 225.00 | 155.90 | 44.32 | 225.00 | 155.90 | 44.32 | 639.60 | 386.00 | 65.70 |
| TAX | 58.30 | 54.80 | 6.39 | 58.30 | 54.80 | 6.39 | 245.10 | 166.70 | 47.03 |
| Deferred Tax | -50.90 | -31.30 | 62.62 | -50.90 | -31.30 | 62.62 | -67.30 | 37.00 | -281.89 |
| PAT | 166.70 | 101.10 | 64.89 | 166.70 | 101.10 | 64.89 | 394.50 | 219.30 | 79.89 |
| Equity | 317.00 | 316.20 | 0.25 | 317.00 | 316.20 | 0.25 | 316.80 | 315.90 | 0.28 |
| PBIDTM(%) | 25.87 | 26.46 | -2.22 | 25.87 | 26.46 | -2.22 | 26.34 | 28.63 | -8.00 |
Read More
Aug
5
2026
Posted on Aug 5th 2026
Alembic Pharma - Quaterly Results
The sales moved up 25.02% to Rs. 18680.60 millions for the June 2026 quarter as compared to Rs. 14941.70 millions during the year-ago period.Net profit for the quarter ended June 2026 increased significantly by 90.26% to Rs. 1969.60 millions from Rs. 1035.20 millions.Operating profit for the quarter ended June 2026 rose to 3598.60 millions as compared to 2215.30 millions of corresponding quarter ended June 2025.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 18680.60 | 14941.70 | 25.02 | 18680.60 | 14941.70 | 25.02 | 66513.80 | 60326.30 | 10.26 |
| Other Income | 140.40 | 77.90 | 80.23 | 140.40 | 77.90 | 80.23 | 559.00 | 478.80 | 16.75 |
| PBIDT | 3598.60 | 2215.30 | 62.44 | 3598.60 | 2215.30 | 62.44 | 11186.10 | 9492.70 | 17.84 |
| Interest | 214.10 | 226.40 | -5.43 | 214.10 | 226.40 | -5.43 | 865.10 | 764.70 | 13.13 |
| PBDT | 3384.50 | 1988.90 | 70.17 | 3384.50 | 1988.90 | 70.17 | 9651.10 | 8856.70 | 8.97 |
| Depreciation | 825.40 | 733.70 | 12.50 | 825.40 | 733.70 | 12.50 | 3110.00 | 2770.80 | 12.24 |
| PBT | 2559.10 | 1255.20 | 103.88 | 2559.10 | 1255.20 | 103.88 | 6541.10 | 6085.90 | 7.48 |
| TAX | 589.50 | 220.00 | 167.95 | 589.50 | 220.00 | 167.95 | 136.90 | 1054.70 | -87.02 |
| Deferred Tax | 156.10 | 0.00 | 0.00 | 156.10 | 0.00 | 0.00 | -1014.50 | 0.00 | 0.00 |
| PAT | 1969.60 | 1035.20 | 90.26 | 1969.60 | 1035.20 | 90.26 | 6404.20 | 5031.20 | 27.29 |
| Equity | 393.10 | 393.10 | 0.00 | 393.10 | 393.10 | 0.00 | 393.10 | 393.10 | 0.00 |
| PBIDTM(%) | 19.26 | 14.83 | 29.93 | 19.26 | 14.83 | 29.93 | 16.82 | 15.74 | 6.88 |
Read More
Aug
5
2026
Posted on Aug 5th 2026
Looks Health Service - Quaterly Results
The topline advanced to Rs. 1.23 millions, up 75.71% for the June 2026 quarter as against Rs. 0.70 millions during the year-ago period.The Company's Net profit for the June 2026 quarter have declined marginally to Rs. 0.02 millions as against Rs. 0.02 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 0.38 millions from 0.38 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 1.23 | 0.70 | 75.71 | 1.23 | 0.70 | 75.71 | 3.88 | 3.95 | -1.77 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 3.90 | -98.97 |
| PBIDT | 0.38 | 0.38 | 0.00 | 0.38 | 0.38 | 0.00 | 1.74 | 1.70 | 2.35 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| PBDT | 0.38 | 0.38 | 0.00 | 0.38 | 0.38 | 0.00 | 1.73 | 1.70 | 1.76 |
| Depreciation | 0.35 | 0.35 | 0.00 | 0.35 | 0.35 | 0.00 | 1.42 | 1.42 | 0.00 |
| PBT | 0.03 | 0.03 | 0.00 | 0.03 | 0.03 | 0.00 | 0.31 | 0.28 | 10.71 |
| TAX | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.08 | 0.05 | 60.00 |
| Deferred Tax | -0.06 | -0.06 | 0.00 | -0.06 | -0.06 | 0.00 | -0.24 | -0.22 | 9.09 |
| PAT | 0.02 | 0.02 | 0.00 | 0.02 | 0.02 | 0.00 | 0.23 | 0.23 | 0.00 |
| Equity | 105.00 | 105.00 | 0.00 | 105.00 | 105.00 | 0.00 | 105.00 | 105.00 | 0.00 |
| PBIDTM(%) | 30.89 | 54.29 | -43.09 | 30.89 | 54.29 | -43.09 | 44.85 | 43.04 | 4.20 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of NG Industries Ltd. is ₹115.00 as of 2026-08-04.
The market capitalisation of NG Industries Ltd. is ₹38.53 as of 2026-08-04.
The 1-year return of NG Industries Ltd. is -44.00% as of 2026-08-04.
The P/E ratio of NG Industries Ltd. is 7.06 as of 2026-08-05.
The 52-week high and low of NG Industries Ltd. are ₹162.00 and ₹111.00, respectively, as of 2026-08-04.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
